Altered JS-2 expression in colorectal cancers and its clinical pathological relevance
- PMID: 21802380
- PMCID: PMC5528300
- DOI: 10.1016/j.molonc.2011.06.003
Altered JS-2 expression in colorectal cancers and its clinical pathological relevance
Abstract
JS-2 is a novel gene located at 5p15.2 and originally detected in primary oesophageal cancer. There is no study on the role of JS-2 in colorectal cancer. The aim of this study is to determine the gene copy number and expression of JS-2 in a large cohort of patients with colorectal tumours and correlate these to the clinicopathological features of the cancer patients. We evaluated the DNA copy number and mRNA expression of JS-2 in 176 colorectal tissues (116 adenocarcinomas, 30 adenomas and 30 non-neoplastic tissues) using real-time polymerase chain reaction. JS-2 expression was also evaluated in two colorectal cancer cell lines and a benign colorectal cell line. JS-2 amplification was noted in 35% of the colorectal adenocarcinomas. Significant differences in relative expression levels for JS-2 mRNA between different colorectal tissues were noted (p = 0.05). Distal colorectal adenocarcinoma had significantly higher copy number than proximal adenocarcinoma (p = 0.005). The relative expression level of JS-2 was different between colonic and rectal adenocarcinoma (p = 0.007). Mucinous adenocarcinoma showed higher JS-2 expression than non-mucinous adenocarcinoma (p = 0.02). Early T-stage cancers appear to have higher JS-2 copy number and lower expression of JS-2 mRNA than later stage cancers (p = 0.001 and 0.03 respectively). Colorectal cancer cell lines showed lower expression of JS-2 than the benign colorectal cell line. JS-2 copy number change and expression were shown for the first time to be altered in the carcinogenesis of colorectal cancer. In addition, genetic alteration of JS-2 was found to be related to location, pathological subtypes and staging of colorectal cancer.
Copyright © 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
Figures
References
-
- Alvarado, M.D. , Jensen, E.H. , Yeatman, T.J. , 2006. The potential role of gene expression in the management of primary and metastatic colorectal cancer. Cancer Control. 13, 27–31. - PubMed
-
- Böhm, M. , Kleine-Besten, R. , Wieland, I. , 2000. Loss of heterozygosity analysis on chromosome 5p defines 5p13-12 as the critical region involved in tumor progression of bladder carcinomas. Int. J. Cancer. 89, 194–197. - PubMed
-
- Fatima, S. , Chui, C.H. , Tang, W.K. , Hui, K.S. , Au, H.W. , Li, W.Y. , Wong, M.M. , Cheung, F. , Tsao, S.W. , Lam, K.Y. , Beh, P.S. , Wong, J. , Law, S. , Srivastava, G. , Ho, K.P. , Chan, A.S. , Tang, J.C. , 2006. Transforming capacity of two novel genes JS-1 and JS-2 located in chromosome 5p and their overexpression in human esophageal squamous cell carcinoma. Int. J. Mol. Med.. 17, 159–170. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
